Cerevel Therapeutics, Inc.
๐บ๐ธUnited States
- Country
- ๐บ๐ธUnited States
- Ownership
- -
- Established
- 2018-01-01
- Employees
- -
- Market Cap
- $8.1B
- Website
- https://www.cerevel.com/
An Open-label Trial to Evaluate Mass Balance of Tavapadon at Steady State in Healthy Subjects
Phase 1
Completed
- Conditions
- Healthy Subjects
- Interventions
- First Posted Date
- 2020-01-27
- Last Posted Date
- 2020-11-17
- Lead Sponsor
- Cerevel Therapeutics, LLC
- Target Recruit Count
- 12
- Registration Number
- NCT04241393
- Locations
- ๐บ๐ธ
Covance Clinical Research Unit, Inc., Madison, Wisconsin, United States
A Single Ascending Dose Trial of CVL-936 in Healthy Subjects
Phase 1
Terminated
- Conditions
- Substance Use Disorders (SUD)
- Interventions
- Drug: Matching Placebo
- First Posted Date
- 2020-01-18
- Last Posted Date
- 2020-06-22
- Lead Sponsor
- Cerevel Therapeutics, LLC
- Target Recruit Count
- 10
- Registration Number
- NCT04232878
- Locations
- ๐บ๐ธ
Hassman Research Institute, Marlton, New Jersey, United States
Fixed-Dose Trial in Early Parkinson's Disease (PD)
- First Posted Date
- 2019-12-17
- Last Posted Date
- 2024-07-29
- Lead Sponsor
- Cerevel Therapeutics, LLC
- Target Recruit Count
- 522
- Registration Number
- NCT04201093
- Locations
- ๐บ๐ธ
Englewood, Colorado, Englewood, Colorado, United States
๐บ๐ธBoca Raton, Florida, Boca Raton, Florida, United States
๐บ๐ธScarborough, Maine, Scarborough, Maine, United States
A Multiple Ascending Dose Trial of CVL-231 in Subjects With Schizophrenia
- First Posted Date
- 2019-10-23
- Last Posted Date
- 2021-07-02
- Lead Sponsor
- Cerevel Therapeutics, LLC
- Target Recruit Count
- 130
- Registration Number
- NCT04136873
- Locations
- ๐บ๐ธ
Synergy San Diego, Lemon Grove, California, United States
๐บ๐ธCollaborative Neuroscience Network, LLC, Long Beach, California, United States
๐บ๐ธPillar Clinical Research, Bentonville, Arkansas, United States
ยฉ Copyright 2025. All Rights Reserved by MedPath